Global: Major patent pool opens up research on neglected disease

Research on drug development for neglected tropical diseases (NTDs), tuberculosis and malaria will receive a boost from a major initiative launched by the World Intellectual Property Organisation (WIPO). 'Re:Search' will provide free access to research on medicines, vaccines and diagnostics, based on patents and research held by a consortium of eight major global pharmaceutical companies, the US National Institutes of Health and other organisations. But only the 49 least developed countries will be able to get a free licence to develop products based on the initiative, a limitation which has been criticised by key organisations in the field such as the Drugs for Neglected Diseases Initiative (DNDi) and the aid organisation Doctors Without Borders.